Autism is the fastest growing developmental disorder in the world.  With 1 child in 91 facing the disorder, diagnosis is common than pediatric cancer, diabetes, and AIDS combined.

While generally considered a neurological disorder, it is not uncommon for autistic children to face additional health challenges, including digestive difficulty, intestinal inflammation, and immunological problems.

Dedicated to the digestive health of all children, Enzymedica. , a leader in digestive enzyme care is committed to support the cause.

In association with the Enzyme Research Group , and the nonprofit educational foundation, Autism Hope Alliance, we invite you to participate in a new survey  designed to evaluate the common digestive concerns of children.

We believe knowledge has the power to change lives.  Your participation in this short survey will help provide hope for others like you facing the diagnosis.

http://www.surveymonkey.com/s/NXYNV5T

The survey should take no more than 10 minutes to complete. No individual results or names will be published in the survey findings report, and results will be presented in aggregate form to protect the confidentiality of your information.

Home: Enzymedica Blog

On Friday, April 2nd, Enzymedica participated in the Light it Up Blue project to show awareness for World Autism Awareness Day.

According to the Light it Up Blue website:

“On the night of April 1, prominent buildings across North America and the world including the Empire State Building in New York City and the CN Tower in Toronto, Canada will be lit up blue to raise awareness for autism and to commemorate World Autism Awareness Day on Friday, April 2.”

Enzymedica actively participates in the autism community via their partnership with the Autism Hope Alliance. (AHA) Dedicated to the recovery of children and adults from autism, the Autism Hope Alliance ignites hope for families facing the diagnosis through education and funding.

To show support for this initiative, Enzymedica employees wore blue, yellow and red to represent the puzzle piece for the Autism Hope Alliance.

The Enzymedica Team

Carol, Hamilton and Becky

Gary, Dorette, Tammy and Dan from The Enzymedica Team

The Enzymedica Team

Home: Enzymedica Blog

Enzymedica is featuring one of their Premiere Research Line products in this month’s spotlight. The Premiere Research product line will includes science-based formulas for cognition, antioxidant, and blood sugar health. The innovative line features bottles in box packaging and metallic accents on the label. Premiere Research is a natural extension of Enzymedica’s award winning, best in class product line up.

Free Radicals

Free radicals are produced as the normal byproducts of metabolism, detoxification, digestion and respiration. They are formed following exposure to pollutants, cigarette smoke, stress, ultraviolet rays and X-rays. This cellular damage can have a profound negative effect on our health, immunity, and overall well-being. The body regulates free radical damage with the help of antioxidants.

Antioxidants

As part of a complex process controlled by the liver, antioxidants are able to help neutralize the free radical cascade, therefore preventing cellular damage. Some antioxidants come from food and supplement sources, while others are produced by the body from the nutrients we consume.

Free Radical Defenze

Enzymedica Defenze blends antioxidants, including superoxide dismutase (SOD) and catalase, with alpha lipoic adic and reduced glutathione, making it one of the most potent and effective antioxidant products available. In clinical trials evaluating caffeine clearance, liver detoxification and glutathione levels, Defenze vastly outperformed a buffered form of vitamin C containing bioflavanoids.

For the month of April, a special discount coupon is available online.

Home: Enzymedica Blog

On Friday, April 2nd, Enzymedica will be participating in the Light it Up Blue project to show awareness for World Autism Awareness Day.

According to the Light it Up Blue website:

“On the night of April 1, prominent buildings across North America and the world including the Empire State Building in New York City and the CN Tower in Toronto, Canada will be lit up blue to raise awareness for autism and to commemorate World Autism Awareness Day on Friday, April 2.”

Enzymedica actively participates in the autism community via their partnership with the Autism Hope Alliance. (AHA) Dedicated to the recovery of children and adults from autism, the Autism Hope Alliance ignites hope for families facing the diagnosis through education and funding.

To show support for this initiative, Enzymedica employees have been invited to wear blue on Friday. Pictures will be coming soon to show how Enzymedica celebrated World Autism Awareness Day.

Home: Enzymedica Blog